Kisspeptin-10 10mg

$40.00

🔬 What Is Kisspeptin-10?

Kisspeptin-10 is a short peptide fragment (10 amino acids long) derived from the larger kisspeptin protein (encoded by the KISS1 gene).
It plays a key role in reproductive hormone regulation by stimulating the release of GnRH (gonadotropin-releasing hormone) from the hypothalamus.
GnRH then signals the pituitary to release LH (luteinizing hormone) and FSH (follicle-stimulating hormone), which regulate sex hormone production (testosterone, estrogen, progesterone).

Fertility treatment:
- Investigated as an alternative to hCG for triggering ovulation in IVF, with lower risk of ovarian hyperstimulation.
- May help men with low sperm production linked to hypothalamic issues.
Hypogonadism: Studied for men with functional hypothalamic hypogonadism (low testosterone due to low GnRH signaling).
Sexual function: Some early studies show kisspeptin can enhance sexual and emotional brain activity.
Research applications: Used in endocrinology to study GnRH and puberty regulation.

Since Kisspeptin-10 is not FDA-approved, dosing protocols come from research/clinic settings:

Common compounding form: 10 mg vial (freeze-dried powder for reconstitution).
Administration: Subcutaneous injection.
Typical research doses:
- 100–300 mcg per injection, given 1–3 times per week.
- Some fertility studies used bolus doses (up to several micrograms/kg IV) in controlled medical settings.

👉 This means a 10 mg vial provides multiple doses, usually drawn into insulin syringes after mixing with bacteriostatic water.

Reported side effects are generally mild: flushing, headache, temporary dizziness, or injection site irritation.
Since it acts on reproductive hormones, it can alter menstrual cycles, ovulation, or testosterone levels.
Long-term safety in humans is not yet well established.

Kisspeptin-10 = short peptide that stimulates GnRH → LH/FSH → sex hormone production.
Main interest: fertility support, reproductive endocrinology, hypogonadism research.
Typical use: 100–300 mcg per injection, several times weekly, from a 10 mg vial.
Status: Experimental outside clinical trials—should be used only under professional guidance.

Quantity:

Kisspeptin-10 is a short peptide fragment (10 amino acids long) derived from the larger kisspeptin protein (encoded by the KISS1 gene).
It plays a key role in reproductive hormone regulation by stimulating the release of GnRH (gonadotropin-releasing hormone) from the hypothalamus.
GnRH then signals the pituitary to release LH (luteinizing hormone) and FSH (follicle-stimulating hormone), which regulate sex hormone production (testosterone, estrogen, progesterone).

Fertility treatment:
- Investigated as an alternative to hCG for triggering ovulation in IVF, with lower risk of ovarian hyperstimulation.
- May help men with low sperm production linked to hypothalamic issues.
Hypogonadism: Studied for men with functional hypothalamic hypogonadism (low testosterone due to low GnRH signaling).
Sexual function: Some early studies show kisspeptin can enhance sexual and emotional brain activity.
Research applications: Used in endocrinology to study GnRH and puberty regulation.

Since Kisspeptin-10 is not FDA-approved, dosing protocols come from research/clinic settings:

Common compounding form: 10 mg vial (freeze-dried powder for reconstitution).
Administration: Subcutaneous injection.
Typical research doses:
- 100–300 mcg per injection, given 1–3 times per week.
- Some fertility studies used bolus doses (up to several micrograms/kg IV) in controlled medical settings.

👉 This means a 10 mg vial provides multiple doses, usually drawn into insulin syringes after mixing with bacteriostatic water.

Reported side effects are generally mild: flushing, headache, temporary dizziness, or injection site irritation.
Since it acts on reproductive hormones, it can alter menstrual cycles, ovulation, or testosterone levels.
Long-term safety in humans is not yet well established.

Kisspeptin-10 = short peptide that stimulates GnRH → LH/FSH → sex hormone production.
Main interest: fertility support, reproductive endocrinology, hypogonadism research.
Typical use: 100–300 mcg per injection, several times weekly, from a 10 mg vial.
Status: Experimental outside clinical trials—should be used only under professional guidance.